John G. Rizk
Impact in
- Virology top 1%
- Poxvirus research and outbreaks
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Youssef Rizk (8 shared papers)Donald N. Forthal (3 shared papers)Giuseppe Lippi (7 shared papers)Brandon Michael Henry (7 shared papers)Carl J. Lavie (8 shared papers)Kamyar Kalantar‐Zadeh (6 shared papers)Mandeep R. Mehra (3 shared papers)Rania M. El-Lababidi (1 shared paper)
- Journals
- Drugs (4 papers)Seminars in Thrombosis and Hemostasis (3 papers)Journal of Managed Care & Specialty Pharmacy (2 papers)Current Opinion in Cardiology (1 paper)Vaccine (1 paper)
- Partner nations
- United StatesLebanonItaly
In The Last Decade
John G. Rizk
29 papers receiving 1.0k citations
John G. Rizk's Hit Papers
Peers
Comparison fields: 5 of 105
- Virology 401
- Internal Medicine 54
- Infectious Diseases 267
- Molecular Medicine 43
- Epidemiology 258
Countries citing papers authored by John G. Rizk
This map shows the geographic impact of John G. Rizk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Rizk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Rizk more than expected).
Fields of papers citing papers by John G. Rizk
This network shows the impact of papers produced by John G. Rizk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Rizk. The network helps show where John G. Rizk may publish in the future.
Co-authors
The 25 scholars most cited alongside John G. Rizk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention and Treatment of Monkeypox Hit paper breakdown → | 2022 | 420 |
| 2 | 2020 | 208 | |
| 3 | 2021 | 81 | |
| 4 | 2020 | 71 | |
| 5 | 2020 | 50 | |
| 6 | 2021 | 44 | |
| 7 | 2021 | 18 | |
| 8 | 2024 | 15 | |
| 9 | 2022 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 10 | |
| 15 | The effect of maternal immunity, age at vaccination and doses or live vaccines on immune response to Newcastle disease. | 1975 | 9 |
| 16 | 2021 | 8 | |
| 17 | 2024 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2024 | 3 |
About John G. Rizk
John G. Rizk is a scholar working on Infectious Diseases, Epidemiology, Neurology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), Long-Term Effects of COVID-19 (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Poxvirus research and outbreaks (3 papers), Bacillus and Francisella bacterial research (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Virology (401 citations), Internal Medicine (54 citations), Infectious Diseases (267 citations), Molecular Medicine (43 citations) and Epidemiology (258 citations). John G. Rizk has collaborated with scholars based in United States, Lebanon and Italy. Frequent co-authors include Youssef Rizk, Donald N. Forthal, Giuseppe Lippi, Brandon Michael Henry, Carl J. Lavie, Kamyar Kalantar‐Zadeh, Mandeep R. Mehra, Rania M. El-Lababidi, John C. Lewin and Partha Sardar. Their work appears in journals such as Drugs, Seminars in Thrombosis and Hemostasis, Journal of Managed Care & Specialty Pharmacy, Current Opinion in Cardiology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.